dihydroxyphenylalanine has been researched along with 2019 Novel Coronavirus Disease in 2 studies
Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hu, T | 1 |
Agazani, O | 1 |
Nir, S | 1 |
Cohen, M | 1 |
Pan, S | 1 |
Reches, M | 1 |
Janeena, A | 1 |
Jayaraman, N | 1 |
Shanmugam, G | 1 |
Easwaramoorthi, S | 1 |
Ayyadurai, N | 1 |
2 other studies available for dihydroxyphenylalanine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Antiviral Activity of Peptide-Based Assemblies.
Topics: Animals; Antiviral Agents; Bacteriophages; Coronavirus; Coronavirus Infections; COVID-19; COVID-19 D | 2021 |
Electrochemical Response of Redox Amino Acid Encoded Fluorescence Protein for Hydroxychloroquine Sensing.
Topics: Amino Acids; COVID-19; COVID-19 Drug Treatment; Dihydroxyphenylalanine; Humans; Hydroxychloroquine; | 2023 |